The NANOS Annual Meeting Neuro-Ophthalmology Collection: Presentations from the annual meeting of the North American Neuro-Ophthalmology Society (NANOS), a professional organization of more than 600 members who are fully trained ophthalmologists or neurologists. Contains records from the first meeting in 1975 to the present.
NOVEL: https://novel.utah.edu/
TO
Filters: Collection: "ehsl_novel_nam"
| Title | Creator | Relation Is Part Of | ||
|---|---|---|---|---|
| 101 |
 |
Bilateral Visual Improvement with Unilateral Gene Therapy for Leber Hereditary Optic Neuropathy (LHON) (PDF) | Nancy J. Newman; Mark Moster; Alfredo Sadun; Thomas Klopstock; Catherine Vignal-Clermont; Valerio Carelli; Patrick Yu Wai Man; Robert Sergott; Valerie Biousse; Laure Blouin; Magali Taiel; Pierre Burguiere; Caroline Chevalier; Katz Barrett; Jose-Alain Sahel | NANOS Annual Meeting 2020: Scientific Platform Session III |
| 102 |
 |
REFLECT Trial: Efficacy and Safety of Bilateral Gene Therapy for Leber Hereditary Optic Neuropathy | Nancy J. Newman; Patrick Yu-Wai-Man; Valerio Carelli; Prem Subramanian; Mark Moster; An-Guor Wang; Sean Donahue; Bart Leroy; Valérie Biousse; Catherine Vignal-Clermont; Alfredo Sadun; Gema Rebolleda Fernández; Elizabeth Fortin; Rudrani Banik; Laure Blouin; Michel Roux; Magali Taiel; José-Alain Sa... | NANOS Annual Meeting 2022: Scientific Platform III |
| 103 |
 |
Treatment with Lenadogene Nolparvovec Gene Therapy Results in Sustained Visual Improvement in m.11778G>A MT-ND4 LHON Patients: the RESTORE Study | Patrick Yu-Wai-Man; Nancy Newman; Valerie Biousse; Valerio Carelli; Mark Moster; Catherine Vignal-Clermont; Thomas Klopstock; Alfredo Sadun; Robert Sergott; Magali Taiel; Josﾎ-Alain Sahel | NANOS Annual Meeting 2023: Poster Session II: Neuro-Ophthalmic Disorders of Neurologic and Systemic Diseases |
| 104 |
 |
Telemedicine 20/20 in 2020: How Far Have We Come, Where Are We Headed and How Is It Relevant to Neuro-Ophthalmology? (PDF) | Melissa W. Ko | NANOS Annual Meeting 2020: Telemedicine |
| 105 |
 |
MS Treatment/Immune System Targets | Robert K. Shin | NANOS Annual Meeting 2023: Neuroimmunology |
| 106 |
 |
Patient-Reported Outcome Measures in Neuro-Ophthalmic Clinical Research | Lindsey B. De Lott | NANOS Annual Meeting 2022: Hot Topics |
| 107 |
 |
Mitochondrial Optic Neuropathies - Expanding Genotypes and Phenotypes | Rustum Karanjia | NANOS Annual Meeting 2022: Mitochondrial Disorders: More Than the Optic Nerve |
| 108 |
 |
Neuro-ophthalmic Complications in Patients Treated with CTLA-4 and PD-1/PD-L1 Checkpoint Blockade Inhibition (PDF) | Eduardo Nicolás Seleme; Michel Sun; John Chen; Anastasia Zekeridou; Elia Sechi; Ryan Walsh; Johanna Beebe; Osama Sabbagh; Luis Mejico; Sean Gratton; Philip Skidd; David Bellows; Julie Falardeau; Clare Fraser; Cecilia Cappelen-Smith; Scott Haines; Bahareh Hassanzadeh; Meagan Seay; Prem Subramanian; ... | NANOS Annual Meeting 2020: Scientific Platform Session I |
| 109 |
 |
Use of Lenadogene Nolparvovec Gene Therapy for Leber Hereditary Optic Neuropathy in Early Access Programs | Catherine Vignal-Clermont; Valerio Carelli; Rabih Hage; Chiara La Morgia; Mark Moster; Robert Sergott; Sean Donahue; Patrick Yu-Wai-Man; Hélène Dollfus; Thomas Klopstock; Claudia Priglinger; Vasily Smirnov; Catherine Cochard; Marie-Benedicte Rougier; Emilie Tournaire-Marques; Pierre Lebranchu; Car... | NANOS Annual Meeting 2023: Poster Session II: Neuro-Ophthalmic Disorders of Neurologic and Systemic Diseases |
| 110 |
 |
rAAV2/2-ND4 Treatment of Leber Optic Neuropathy: 72-Week Data from the REVERSE Phase III Clinical Trial | Nancy J. Newman; Mark Moster; Alfredo Sadun; Thomas Klopstock; Catherine Vignal; Valerio Carelli; Patrick Yu-Wai-Man; Jose Sahel; Barrett Katz | NANOS 2019: Scientific Platform III |
| 111 |
 |
Neuro-Ophthalmic Consequences of Medications for Multiple Sclerosis: The Good, The Bad, The Ugly and The Unknown (abstract) | Heather E. Moss, MD, PhD | NANOS 2017: Neuro-Ophthalmologic Side Effects of More Recently Used Medications in Treating Cancer, Rheumatologic Disorders, and Multiple Sclerosis |
| 112 |
 |
Literature Relevant to Optic Nerve and Retinal Ganglion Cells | Nitza Goldenberg-Cohen | NANOS Annual Meeting 2018: Literature Review |
| 113 |
 |
Practical Telemedicine: Validated Mobile Apps | Linus D. Sun | NANOS Annual Meeting 2021: Tele-Neuro-Ophthalmology: Updates and Future Implications |
| 114 |
 |
Gene Therapy - Evolution and Therapeutic Applications (PDF) | Patrick Yu-Wai-Man | NANOS Annual Meeting 2020: New Treatments in Neuro-Ophthalmology-2020 Trends |
| 115 |
 |
Pediatric Neuromuscular Disorders | Veeral Shah, MD, PhD | NANOS 2019: Current Concepts in Eye Movement Disorders in Kids: Case-based Potpourri |
| 116 |
 |
VZV and the CNS | Joseph Berger, MD | NANOS Annual Meeting 2018: Varicella Zoster Virus (VZV) in Neuro-Ophthalmology |
| 117 |
 |
Electroretinography (ERG) Monitoring for Vigabatrin Visual Toxicity (The Pros and The Cons) - ERG versus No ERG with; Clinical Follow-Up (ERG Beneficial & ERG Not Beneficial) | Steven F. Stasheff, MD, PhD | NANOS Annual Meeting 2021: Controversies in Pediatric Neuro-Ophthalmology |
| 118 |
 |
The Diversity Benefit - NANOS Diversity Report (Telehealth: A Potential Solution to the Workforce and Diversity Problem or Not?) | Kevin E. Lai, MD | NANOS Annual Meeting 2023: The Future of NO - Diversity, Equity, and Inclusion: https://novel.utah.edu/collection/NAM/toc/ |
| 119 |
 |
A Randomized Prospective Trial Comparing Repository Corticotropin Injection and Intravenous Methylprednisolone in Acute Optic Neuritis | Jeffrey Bennett, MD, PhD | NANOS Annual Meeting 2022: Scientific Platform Session II |
| 120 |
 |
Neuro-ophthalmic Complications in Patients Treated with CTLA-4 and PD-1/PD-L1 Checkpoint Blockade Inhibition (Slides) | Eduardo Nicolás Seleme; Michel Sun; John Chen; Anastasia Zekeridou; Elia Sechi; Ryan Walsh; Johanna Beebe; Osama Sabbagh; Luis Mejico; Sean Gratton; Philip Skidd; David Bellows; Julie Falardeau; Clare Fraser; Cecilia Cappelen-Smith; Scott Haines; Bahareh Hassanzadeh; Meagan Seay; Prem Subramanian; ... | NANOS Annual Meeting 2020: Scientific Platform Session I |
| 121 |
 |
Literature Review: Developments in Disease Mechanisms and Treatment | Leonard A. Levin | NANOS Annual Meeting 2018: Literature Review |
| 122 |
 |
Driving Considerations in Teens with Optic Neuropathies (abstract) | Judith E. Goldstein, OD | NANOS 2017: Afferent and Efferent Rehabilitative Strategies in Neuro-Ophthalmology |
| 123 |
 |
Elevated Intracranial Pressures and Papilledema in a Mouse Model of Glucocorticoid Induced Adrenal Insufficiency | Kevin Zhang; Yuying Cao; Jonathan Mercado-Reyes; Veeral Shah | NANOS Annual Meeting 2023: Scientific Platform Session II: https://novel.utah.edu/collection/NAM/toc/ |
| 124 |
 |
Telemedicine: Does It Pay to Play? Billing, Coding, Reimbursement (PDF) | Kevin E. Lai, MD | NANOS Annual Meeting 2020: Telemedicine |
| 125 |
 |
Neuro-Ophthalmic Consequences of Immune Therapy (PDF) | Lynn K. Gordon | NANOS Annual Meeting 2020: New Treatments in Neuro-Ophthalmology-2020 Trends |